Health Condition 1: C189- Malignant neoplasm of colon, unspecified Health Condition 2: C14- Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
Conditions
Interventions
Intervention1: Blood and tissue sample collection: The study has been classified as interventional as we are collecting tissue and blood samples from the patients
Control Intervention1: NA: NA
Sponsors
BIRAC
baseCare Genomics Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Persons above 18 years of age, diagnosed with HNSCC or CRC, any grade, any stage, chemo-naïve or previously treated and unresponsive to treatment, capable of giving consent
Exclusion criteria
Exclusion criteria: Persons without HNSCC or CRC or those incapable of giving consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢Improved understanding of the response of patients to cancer therapeutics based on their correlation to various factors. â?¢Better ability to predict therapy response and match patients with the right treatment options compared to conventional approaches, in both CRC and HNSCC. Timepoint: 18 months | — |
Secondary
| Measure | Time frame |
|---|---|
| NoneTimepoint: None | — |
Countries
India
Contacts
Public ContactDr Rakesh Katna
Vedant Hospital
Outcome results
None listed